Analyst Josh Jennings of TD Cowen maintained a Buy rating on Ceribell, Inc. (CBLL – Research Report), retaining the price target of $36.00.
Josh Jennings has given his Buy rating due to a combination of factors that highlight Ceribell, Inc.’s strong financial performance and growth potential. The company exceeded expectations in the fourth quarter, with sales reaching $18.5 million, surpassing both its own guidance and market forecasts. This impressive performance marks the second consecutive quarter of outpacing sales targets since becoming a public entity, showcasing Ceribell’s ability to deliver consistent top-line growth.
Furthermore, the company’s strategic focus on expanding its commercial organization and increasing utilization among existing users is expected to drive further growth. With promising sales growth guidance for 2025 and several new indications in the pipeline, Ceribell is poised for long-term success. The company’s robust gross margin of 88% and a strong cash position of $194.4 million further support its capacity to invest in future growth opportunities, making it an attractive investment option.
Questions or Comments about the article? Write to editor@tipranks.com